Tree of Knowledge International Achieves Historic Cross Listing with the Jamaican Stock Exchange
24 Janvier 2020 - 12:54PM
InvestorsHub NewsWire
Tree of Knowledge International
Achieves Historic Cross Listing with the Jamaican Stock
Exchange
TORONTO, ON, Canada -- January 24, 2020 -- InvestorsHub NewsWire
-- In a historic moment, Tree of Knowledge International Corp.
(TOKI) (CSE:
TOKI –
OTC: TOKIF) will become the first company to be
cross-listed between the Canadian Securities Exchange (CSE) and the
Jamaican Stock Exchange (JSE). TOKI is building on its
already established thousands of patients in Canada with access to
up to a further 1.5 million patients through its strategic
partnership with Jack Nathan health clinics (as reported in March
2019) by developing and distribution of a diverse range of
protocols and treatments for pain management. The
cross-listing is a major step by Tree of Knowledge to play a
leading role internationally in the estimated 4.2 trillion health
and wellness industry (as reported in 2017 by the
Global Wellness Institute.)
“The CSE is very pleased to see Tree of Knowledge International
Corp. access the Jamaican market with a listing on the JSE,” stated
Rob Cook, Senior VP of Market Development of the Canadian
Securities Exchange. “This is one of the outcomes that we envisaged
when we entered into a Memorandum of Understanding with the JSE in
2019. Both exchanges endeavor to give their listed companies the
full benefit of public company experience in a liquid and well
regulated market.”
Minister Audley Shaw the Minister of Industry, Commerce,
Agriculture, and Fisheries in Jamaica is excited at the
investment opportunity that this cross-listing will provide to
investors. “This cross listing paves the way for the Jamaican
diaspora to reap the benefits of our rapidly developing Health and
Wellness industry by investing in a publicly traded company on the
Jamaican Exchange – recognized by Bloomberg as the best performing stock
exchange in the world.” The cross listing opens numerous
opportunities for both Tree of Knowledge and Jamaica, he
added.
“Tree of Knowledge has already established significant
partnerships in Jamaica. This cross listing provides Jamaicans and
the Jamaican diaspora with the opportunity to invest in the first
international publicly listed company on the Jamaican stock
exchange,” stated TOKI’s CEO Michael Caridi. “Our vision for
Jamaica is to be the bridge between Jamaica’s Health and Wellness
industry and the rest of the world using Jamaica as our strategic
location to develop the Caribbean and Latin American markets where
Tree of Knowledge products will gain access to the region.
The trading start date along with the JSE trading symbol will be
announced soon.
About Tree of Knowledge
With its head office in Toronto, and operations in North York,
Ontario and Spokane, Washington, TOKI currently has three primary
business segments: (1) Multidisciplinary specialty pain clinics
with a focus on the treatment of chronic pain, including controlled
applications of medical cannabis in Canada, (2) Development of
formulated products for therapeutic purposes and natural health
product alternatives at its manufacturing facility in Spokane,
which provides formulations for the Company's products and for
third parties equivalent to GMP standards, and (3) Distribution and
sale of hemp-based cannabidiol ("CBD") products in the United
States, Canada, Europe, Brazil and Australia. Through its Toronto
Poly Clinic, the Company has gleaned extensive expertise from being
involved in one of the largest observational clinical trials on
medical cannabis and from its ongoing direct patient experience.
The Company has developed and implemented MCERP (Medical Cannabis
Education, Research and Best Practice Platform) and MCORP (Medical
Cannabis Opioid Reduction Program) with great success. Currently,
the Company has research agreements with multiple universities for
medical cannabis research and new medical grade product
development. TOKI's CBD product line contains EVR Premium Hemp Oil,
which is an organically grown and handled, gluten-free, vegan,
non-GMO, synergistic compound that is derived from U.S. Department
of Agriculture (USDA) approved industrial hemp grown in the United
States. TOKI currently offers several CBD products, which may be
used in connection with the treatment of a number of ailments and
for general wellness purposes.
Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements” within
the meaning of the United States Private Securities Litigation
Reform Act of 1995 and “forward-looking information” within the
meaning of applicable Canadian securities legislation. Often, but
not always, forward-looking statements and information can be
identified by the use of words such as “plans”, “expects” or “does
not expect”, “is expected”, “estimates”, “intends”, “anticipates”
or “does not anticipate”, or “believes”, or variations of such
words and phrases or state that certain actions, events or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking statements or information involve known
and unknown risks, uncertainties and other factors which may cause
the actual results, performance or achievements of Canopy Growth or
its subsidiaries to be materially different from any future
results, performance or achievements expressed or implied by the
forward-looking statements or information contained in this news
release. Examples of such statements include statements with
respect to future product format offerings. Risks, uncertainties
and other factors involved with forward-looking information could
cause actual events, results, performance, prospects and
opportunities to differ materially from those expressed or implied
by such forward-looking information, including the Company’s
ability to satisfy provincial sales contracts or provinces
purchasing all cannabis allocated to them, and such risks contained
in the Company’s annual information form dated June 25, 2019 and
filed with Canadian securities regulators available on the
Company’s issuer profile on SEDAR at www.sedar.com. Although the
Company believes that the assumptions and factors used in preparing
the forward-looking information or forward-looking statements in
this news release are reasonable, undue reliance should not be
placed on such information and no assurance can be given that such
events will occur in the disclosed time frames or at all. The
forward-looking information and forward-looking statements included
in this news release are made as of the date of this news release
and the Company does not undertake an obligation to publicly update
such forward-looking information or forward-looking information to
reflect new information, subsequent events or otherwise unless
required by applicable securities laws.
Contact:
Tree of Knowledge International Corp.
Natasha Raey
Media Relations
pr@tokicorp.com
778-552-4538
Optima Medical Innovations (CE) (USOTC:TOKIF)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Optima Medical Innovations (CE) (USOTC:TOKIF)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024